SOSTDC1 inhibits bone metastasis in non-small cell lung cancer and may serve as a clinical therapeutic target

Chen,Guanghui; Gong,Haiyi; Wang,Ting; Wang,Jian; Han,Zhitao; Bai,Guangjian; Han,Shuai; Yang,Xinghai; Zhou,Wang; Liu,Tielong; Xiao,Jianru

doi:10.3892/ijmm.2018.3926

SOSTDC1 inhibits bone metastasis in non-small cell lung cancer and may serve as a clinical therapeutic target

Authors:
- Guanghui Chen
- Haiyi Gong
- Ting Wang
- Jian Wang
- Zhitao Han
- Guangjian Bai
- Shuai Han
- Xinghai Yang
- Wang Zhou
- Tielong Liu
- Jianru Xiao
View Affiliations

Affiliations: Orthopedic Oncology Center, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China, Department of Orthopedics, Pudong New District People's Hospital, Shanghai 201200, P.R. China, Department of Orthopedics, Affiliated Hospital of Taishan Medical University, Taishan Medical University, Tai'an, Shandong 271016, P.R. China
Published online on: October 10, 2018 https://doi.org/10.3892/ijmm.2018.3926
Pages: 3424-3436
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Bone metastasis occurs in ~40% patients with non‑small cell lung cancer (NSCLC), resulting in serious morbidity and mortality. Sclerostin domain‑containing protein 1 (SOSTDC1) has been demonstrated to be associated with the development and progression of multiple types of cancer. However, the role of SOSTDC1 in NSCLC bone metastasis remains unclear. In the present study, it was identified that SOSTDC1 was downregulated in NSCLC bone metastatic lesions compared with that in primary tumors, and low SOSTDC1 expression predicted poor prognosis for patients with NSCLC. Functionally, SOSTDC1 overexpression suppressed NSCLC cell proliferation, migration, invasion and cancer cell‑induced osteoclastogenesis, while SOSTDC1 knockdown produced the opposite effect. In addition, a number of potential downstream target genes of SOSTDC1, which were demonstrated to be associated with tumor progression and bone metastasis, were identified in NSCLC cells by RNA deep sequencing and RT‑qPCR assays. The results from the present study may provide useful insight for an improved understanding of the pathogenesis of NSCLC bone metastasis, and suggest that SOSTDC1 may be a potential prognostic biomarker and therapeutic target for NSCLC bone metastasis.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
2	Howlader N, Noone AM, Yu M and Cronin KA: Use of imputed population-based cancer registry data as a method of accounting for missing information: Application to estrogen receptor status for breast cancer. Am J Epidemiol. 176:347–356. 2012. View Article : Google Scholar : PubMed/NCBI
3	Hoffman PC, Mauer AM and Vokes EE: Lung cancer. Lancet. 355:479–485. 2000. View Article : Google Scholar : PubMed/NCBI
4	DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
5	Vicent S, Luis-Ravelo D, Antón I, García-Tuñón I, Borrás-Cuesta F, Dotor J, De Las, Rivas J and Lecanda F: A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism. Cancer Res. 68:2275–2285. 2008. View Article : Google Scholar : PubMed/NCBI
6	Ahn Y, Sims C, Murray MJ, Kuhlmann PK, Fuentes-Antrás J, Weatherbee SD and Krumlauf R: Multiple modes of Lrp4 function in modulation of Wnt/β-catenin signaling during tooth development. Development. 144:2824–2836. 2017. View Article : Google Scholar : PubMed/NCBI
7	Närhi K, Tummers M, Ahtiainen L, Itoh N, Thesleff I and Mikkola ML: Sostdc1 defines the size and number of skin appendage placodes. Dev Biol. 364:149–161. 2012. View Article : Google Scholar : PubMed/NCBI
8	Collette NM, Yee CS, Murugesh D, Sebastian A, Taher L, Gale NW, Economides AN, Harland RM and Loots GG: Sost and its paralog Sostdc1 coordinate digit number in a Gli3-dependent manner. Dev Biol. 383:90–105. 2013. View Article : Google Scholar : PubMed/NCBI
9	Shigetani Y, Howard S, Guidato S, Furushima K, Abe T and Itasaki N: Wise promotes coalescence of cells of neural crest and placode origins in the trigeminal region during head development. Dev Biol. 319:346–358. 2008. View Article : Google Scholar : PubMed/NCBI
10	Liang W, Guan H, He X, Ke W, Xu L, Liu L, Xiao H and Li Y: Down-regulation of SOSTDC1 promotes thyroid cancer cell proliferation via regulating cyclin A2 and cyclin E2. Oncotarget. 6:31780–31791. 2015. View Article : Google Scholar : PubMed/NCBI
11	Rawat A, Gopisetty G and Thangarajan R: E4BP4 is a repressor of epigenetically regulated SOSTDC1 expression in breast cancer cells. Cell Oncol. 37:409–419. 2014. View Article : Google Scholar
12	Gopal G, Raja UM, Shirley S, Rajalekshmi KR and Rajkumar T: SOSTDC1 down-regulation of expression involves CpG methylation and is a potential prognostic marker in gastric cancer. Cancer Genet. 206:174–182. 2013. View Article : Google Scholar : PubMed/NCBI
13	Blish KR, Wang W, Willingham MC, Du W, Birse CE, Krishnan SR, Brown JC, Hawkins GA, Garvin AJ, D’Agostino RB Jr, et al: A human bone morphogenetic protein antagonist is down-regulated in renal cancer. Mol Biol Cell. 19:457–464. 2008. View Article : Google Scholar :
14	Zhou Q, Chen J, Feng J, Xu Y, Zheng W and Wang J: SOSTDC1 inhibits follicular thyroid cancer cell proliferation, migration, and EMT via suppressing PI3K/Akt and MAPK/Erk signaling pathways. Mol Cell Biochem. 435:87–95. 2017. View Article : Google Scholar : PubMed/NCBI
15	Henley KD, Gooding KA, Economides AN and Gannon M: Inactivation of the dual Bmp/Wnt inhibitor Sostdc1 enhances pancreatic islet function. Am J Physiol Endocrinol Metab. 303:E752–E761. 2012. View Article : Google Scholar : PubMed/NCBI
16	Itasaki N, Jones CM, Mercurio S, Rowe A, Domingos PM, Smith JC and Krumlauf R: Wise, a context-dependent activator and inhibitor of Wnt signalling. Development. 130:4295–4305. 2003. View Article : Google Scholar : PubMed/NCBI
17	Liu L, Wu S, Yang Y, Cai J, Zhu X, Wu J, Li M and Guan H: SOSTDC1 is down-regulated in non-small cell lung cancer and contributes to cancer cell proliferation. Cell Biosci. 6:242016. View Article : Google Scholar : PubMed/NCBI
18	Koul R, Rathod S, Dubey A, Bashir B and Chowdhury A: Comparison of 7th and 8th editions of the UICC/AJCC TNM staging for nonsmall cell lung cancer in a non-metastatic North American cohort undergoing primary radiation treatment. Lung Cancer. 123:116–120. 2018. View Article : Google Scholar : PubMed/NCBI
19	Driver BR, Barrios R, Ge Y, Haque A, Tacha D and Cagle PT: Folate receptor α expression level correlates with histologic grade in lung adenocarcinoma. Arch Pathol Lab Med. 140:682–685. 2016. View Article : Google Scholar
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔ^C T method. Methods. 25:402–408. 2001. View Article : Google Scholar
21	Wang T, Yin H, Wang J, Li Z, Wei H, Liu Z, Wu Z, Yan W, Liu T, Song D, et al: MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of bone. Oncotarget. 6:18980–18996. 2015.PubMed/NCBI
22	Zhou W, Yin H, Wang T, Liu T, Li Z, Yan W, Song D, Chen H, Chen J, Xu W, et al: MiR-126-5p regulates osteolysis formation and stromal cell proliferation in giant cell tumor through inhibition of PTHrP. Bone. 66:267–276. 2014. View Article : Google Scholar : PubMed/NCBI
23	Laurikkala J, Kassai Y, Pakkasjärvi L, Thesleff I and Itoh N: Identification of a secreted BMP antagonist, ectodin, integrating BMP, FGF, and SHH signals from the tooth enamel knot. Dev Biol. 264:91–105. 2003. View Article : Google Scholar : PubMed/NCBI
24	Kamiya N: The role of BMPs in bone anabolism and their potential targets SOST and DKK1. Curr Mol Pharmacol. 5:153–163. 2012. View Article : Google Scholar
25	Okamoto M, Murai J, Yoshikawa H and Tsumaki N: Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. J Bone Miner Res. 21:1022–1033. 2006. View Article : Google Scholar : PubMed/NCBI
26	Collette NM, Yee CS, Hum NR, Murugesh DK, Christiansen BA, Xie L, Economides AN, Manilay JO, Robling AG and Loots GG: Sostdc1 deficiency accelerates fracture healing by promoting the expansion of periosteal mesenchymal stem cells. Bone. 88:20–30. 2016. View Article : Google Scholar : PubMed/NCBI
27	Togo Y, Takahashi K, Saito K, Kiso H, Tsukamoto H, Huang B, Yanagita M, Sugai M, Harada H, Komori T, et al: Antagonistic functions of USAG-1 and RUNX2 during tooth development. PLoS One. 11:e01610672016. View Article : Google Scholar : PubMed/NCBI
28	Fujita K, Roforth MM, Demaray S, McGregor U, Kirmani S, McCready LK, Peterson JM, Drake MT, Monroe DG and Khosla S: Effects of estrogen on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in postmenopausal women. J Clin Endocrinol Metab. 99:E81–E88. 2014. View Article : Google Scholar :
29	Prochazkova M, Häkkinen TJ, Prochazka J, Spoutil F, Jheon AH, Ahn Y, Krumlauf R, Jernvall J and Klein OD: FGF signaling refines Wnt gradients to regulate the patterning of taste papillae. Development. 144:2212–2221. 2017. View Article : Google Scholar : PubMed/NCBI
30	Lee JW, Wang P, Kattah MG, Youssef S, Steinman L, DeFea K and Straus DS: Differential regulation of chemokines by IL-17 in colonic epithelial cells. J Immunol. 181:6536–6545. 2008. View Article : Google Scholar : PubMed/NCBI
31	Kanda N, Hau CS, Tada Y, Tatsuta A, Sato S and Watanabe S: Visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes. Endocrinology. 152:3155–3164. 2011. View Article : Google Scholar : PubMed/NCBI
32	Hardaway AL, Herroon MK, Rajagurubandara E and Podgorski I: Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer. Clin Exp Metastasis. 32:353–368. 2015. View Article : Google Scholar : PubMed/NCBI
33	Liu P, Lee S, Knoll J, Rauch A, Ostermay S, Luther J, Malkusch N, Lerner UH, Zaiss MM, Neven M, et al: Loss of menin in osteoblast lineage affects osteocyte-osteoclast crosstalk causing osteoporosis. Cell Death Differ. 24:672–682. 2017. View Article : Google Scholar : PubMed/NCBI